BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12901595)

  • 1. Advances in the development of bacterial vector technology.
    Kochi SK; Killeen KP; Ryan US
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL; Tinge SA; Killeen KP; Kochi SK
    Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The history of live bacterial vaccines.
    Lindberg AA
    Dev Biol Stand; 1995; 84():211-9. PubMed ID: 7796956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live bacterial delivery systems for development of mucosal vaccines.
    Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
    Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances with recombinant bacterial vaccine vectors.
    Shata MT; Stevceva L; Agwale S; Lewis GK; Hone DM
    Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.
    Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA
    Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of gene-based vaccines.
    Barouch DH
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant vector vaccines in vaccinology.
    Hilleman MR
    Dev Biol Stand; 1994; 82():3-20. PubMed ID: 7958480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Listeria-based vaccines for cancer treatment.
    Paterson Y; Maciag PC
    Curr Opin Mol Ther; 2005 Oct; 7(5):454-60. PubMed ID: 16248280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of live recombinant BCG vaccines.
    Hanson MS; Bansal GP; Langermann S; Stover CK; Orme I
    Dev Biol Stand; 1995; 84():229-36. PubMed ID: 7796958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D; Weidinger G; Spreng S
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
    Brockstedt DG; Dubensky TW
    Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.